-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
-
Summary
-
KalVista Pharmaceuticals, Inc. quarterly Deferred Tax Assets, Net of Valuation Allowance history and growth rate from Q4 2014 to Q1 2024.
- KalVista Pharmaceuticals, Inc. Deferred Tax Assets, Net of Valuation Allowance for the quarter ending April 30, 2024 was $1.43M, a 18.8% decline year-over-year.
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Growth (%)